POLY MVA UTILIZED AS NEUROPROTEIN IN CHRONIC HYPERTENSION

聚 MVA 作为神经蛋白用于治疗慢性高血压

• 批准号: 7375385
• 负责人: CANDICE J PERKINS
• 金额: $ 0.73万
• 依托单位: STATE UNIVERSITY NEW YORK STONY BROOK
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7375385
• 关键词: POLY; MVA; UTILIZED; NEUROPROTEIN; CHRONIC

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Some people with a history of high blood pressure develop hardening and reduced flow in the deep blood vessel of the brain. This results in areas of decreased oxygen delivery, which then results in decreased energy supply and possible brain cell death. This condition is called " Small Vessel Disease" (SVD) . There is no current FDA-approved treatment for this condition. We at Stony Brook have been studying the effects of a dietary supplement , Poly-MVA, as a protection against Small Vessel Disease. This supplement acts as an "energy boost" ; it has the ability to transfer energy to cells. We believe this may prevent cell death in vunerable areas.

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子弹和调查员（PI）可能已经从其他NIH来源获得了主要资金，因此可以在其他清晰的条目中代表。列出的机构适用于该中心，这不一定是调查员的机构。有些具有高血压史的人会在大脑深血管中会变硬和流量减少。这导致氧气递送减少，然后导致能量供应减少和可能的脑细胞死亡。这种情况称为“小血管疾病”（SVD）。对于这种情况，目前没有FDA批准的治疗方法。 Stony Brook的我们一直在研究饮食补充剂Poly-MVA的影响，以保护小血管疾病。这种补充是一种“能量提升”。它具有将能量转移到细胞的能力。我们认为，这可能会防止可验证的地区的细胞死亡。